Cargando…

Anticoagulation Strategies in Venovenous Hemodialysis in Critically Ill Patients: A Five-Year Evaluation in a Surgical Intensive Care Unit

Renal failure is a common complication among critically ill patients. Timing, dosage, and mode of renal replacement (RRT) are under debate, but also anticoagulation strategies and vascular access interfere with dialysis success. We present a retrospective, five-year evaluation of patients requiring...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sponholz, Christoph, Bayer, Ole, Kabisch, Björn, Wurm, Karin, Ebert, Katharina, Bauer, Michael, Kortgen, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274656/ https://www.ncbi.nlm.nih.gov/pubmed/25548793 http://dx.doi.org/10.1155/2014/808320

Ejemplares similares

Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis
por: Kalb, R, et al.
Publicado: (2011)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

Population pharmacokinetic modeling of multiple-dose intravenous fosfomycin in critically ill patients during continuous venovenous hemodialysis
por: Hüppe, Tobias, et al.
Publicado: (2023)

Extracorporeal albumin dialysis in critically ill patients with liver failure: Comparison of four different devices—A retrospective analysis
por: Sommerfeld, Oliver, et al.
Publicado: (2023)

A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients
por: Leung, Anne Kit-Hung, et al.
Publicado: (2013)

Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
por: Schultheiß, Caroline, et al.
Publicado: (2012)

Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial
por: Ratanarat, Ranistha, et al.
Publicado: (2023)

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
por: Slowinski, Torsten, et al.
Publicado: (2015)

Putative novel mediators of acute kidney injury in critically ill patients: handling by continuous venovenous hemofiltration and effect of anticoagulation modalities
por: Schilder, Louise, et al.
Publicado: (2015)

Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

Anticoagulation in COVID-19-positive Patients on Venovenous Extracorporeal Membrane Oxygenation
por: Patel, Mayuri, et al.
Publicado: (2022)

Recurrent early filter clotting in regional citrate anticoagulated continuous venovenous hemodialysis due to undetected antibodies to heparin-platelet factor 4 complexes
por: Slowinski, T, et al.
Publicado: (2010)

Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)
por: Wilson, F. Perry, et al.
Publicado: (2012)

Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
por: Aguilar, Gerardo, et al.
Publicado: (2017)

Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children
por: Peng, Lengyue, et al.
Publicado: (2021)

Use of Venovenous Extracorporeal Membrane Oxygenation in Critically-Ill Patients With COVID-19
por: Jozwiak, Mathieu, et al.
Publicado: (2020)

Regional citrate anticoagulation (RCA) for continuous venovenous hemodiafiltration (CVVHDF): initial experience
por: Durão, M, et al.
Publicado: (2001)

Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19
por: Seelhammer, Troy G., et al.
Publicado: (2021)

Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
por: Lenga, Ilan, et al.
Publicado: (2019)

Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?
por: Lösche, Wolfgang, et al.
Publicado: (2012)

The plasma level and biomarker value of neutrophil gelatinase-associated lipocalin in critically ill patients with acute kidney injury are not affected by continuous venovenous hemofiltration and anticoagulation applied
por: Schilder, Louise, et al.
Publicado: (2014)

Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial
por: Schilder, Louise, et al.
Publicado: (2014)

Evaluation of the predilution technique in reducing the occurrence of bleeding during continuous venovenous haemofiltration in critically ill patients. Efficacy of predilution in reducing the amount of anticoagulation during CVVH
por: Honore, PM, et al.
Publicado: (1997)

Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
por: Aguilar, Gerardo, et al.
Publicado: (2019)

Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients
por: Perez Ruiz de Garibay, Aritz, et al.
Publicado: (2022)

Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients
por: Schilder, Louise, et al.
Publicado: (2014)

Severe Metformin Poisoning Successfully Treated with Simultaneous Venovenous Hemofiltration and Prolonged Intermittent Hemodialysis
por: Leonaviciute, Dovile, et al.
Publicado: (2018)

Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit
por: Claisse, Guillaume, et al.
Publicado: (2015)

Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
por: dos Santos, Thais Oliveira Claizoni, et al.
Publicado: (2023)

Clinical impact of a PCR-based assay for pathogen detection in critically ill patients with evidence of infection
por: Bloos, F, et al.
Publicado: (2009)

Determinants of Outcome in Non-Septic Critically Ill Patients with Acute Kidney Injury on Continuous Venovenous Hemofiltration
por: Koning, Mark V., et al.
Publicado: (2011)

High-volume continuous venovenous hemofiltration reduces mortality in critically ill patients with acute renal failure
por: Van Ketel, R, et al.
Publicado: (2008)

An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration
por: D’Arcy, Deirdre M, et al.
Publicado: (2012)

Regional citrate anticoagulation for intermittent hemodialysis in the intensive care: what is the optimal setup?
por: Gubensek, Jakob, et al.
Publicado: (2021)

Pilot study on a regional citrate anticoagulated continuous venovenous hemodiafiltration protocol with variable treatment dose
por: Slowinski, T, et al.
Publicado: (2010)

Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization
por: Nogier, MB, et al.
Publicado: (2009)

Analysis of Related Factors of Early Mortality in Patients with Severe Renal Injury Treated with Continuous Venovenous Hemodialysis
por: Wang, Qingyun, et al.
Publicado: (2022)

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation
por: Mariat, Christophe, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_195k7gh52de47hqvf6tdcd7unp